Ahad Sadiq

Hematology | Oncology
7910 W Jefferson Blvd Ste 108
Fort Wayne, IN 46804

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Two Phase II Trials of Adavosertib, a Wee1 Inhibitor with Docetaxel or Carboplatin plus Pemetrexed in Non-small-cell Lung Cancer.

Two Phase II Trials of Adavosertib, a Wee1 Inhibitor with Docetaxel or Carboplatin plus Pemetrexed in Non-small-cell Lung Cancer.

Journal: Targeted oncology
Published: February 02, 2025

A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN 14-179.

A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN 14-179.

Journal: Cancer
Published: February 04, 2020

Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsy.

Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsy.

Journal: Journal of gastrointestinal oncology
Published: October 12, 2019

Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype-Guided Dosing.

Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype-Guided Dosing.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 13, 2019

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial.

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial.

Journal: The Lancet. Oncology
Published: October 25, 2018

4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma.

4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma.

Journal: Investigational new drugs
Published: August 17, 2017

Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma.

Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma.

Journal: Oncotarget
Published: March 12, 2017

Measles vaccine strains for virotherapy of non-small-cell lung carcinoma.

Measles vaccine strains for virotherapy of non-small-cell lung carcinoma.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 27, 2014

Resistance to EGFR-TKI can be mediated through multiple signaling pathways converging upon cap-dependent translation in EGFR-wild type NSCLC.

Resistance to EGFR-TKI can be mediated through multiple signaling pathways converging upon cap-dependent translation in EGFR-wild type NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 26, 2013

MET as a possible target for non-small-cell lung cancer.

MET as a possible target for non-small-cell lung cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 13, 2013

Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factor.

Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factor.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 20, 2012

Utilisation of a thoracic oncology database to capture radiological and pathological images for evaluation of response to chemotherapy in patients with malignant pleural mesothelioma.

Utilisation of a thoracic oncology database to capture radiological and pathological images for evaluation of response to chemotherapy in patients with malignant pleural mesothelioma.

Journal: BMJ open
Published: October 30, 2012
Showing 1-12 of 13

Last Updated: 09/26/2026